{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:36:09Z","timestamp":1790771769051,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"publisher","award":["2022-2-4084"],"award-info":[{"award-number":["2022-2-4084"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05854-9","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T15:24:36Z","timestamp":1731684276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinoma"],"prefix":"10.1186","volume":"22","author":[{"given":"Delin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengkang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuomiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingming","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuyin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiye","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"issue":"3","key":"5854_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"5854_CR2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.4155\/fmc.13.62","volume":"5","author":"I Ali","year":"2013","unstructured":"Ali I, Wani WA, Haque A, Saleem K. Glutamic acid and its derivatives: candidates for rational design of anticancer drugs. Future Med Chem. 2013;5(8):961\u201378.","journal-title":"Future Med Chem"},{"issue":"1","key":"5854_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/157340613804488297","volume":"9","author":"I Ali","year":"2013","unstructured":"Ali I, Wani WA, Saleem K, Wesselinova D. Syntheses, DNA binding and anticancer profiles of l-glutamic acid ligand and its copper(II) and ruthenium(III) complexes. Med Chem. 2013;9(1):11\u201321.","journal-title":"Med Chem"},{"issue":"56","key":"5854_CR4","doi-asserted-by":"publisher","first-page":"29629","DOI":"10.1039\/C4RA02570A","volume":"4","author":"I Ali","year":"2014","unstructured":"Ali I, Wani WA, Saleem K, Hsieh M-F. Anticancer metallodrugs of glutamic acid sulphonamides: in silico, DNA binding, hemolysis and anticancer studies. RSC Adv. 2014;4(56):29629\u201341.","journal-title":"RSC Adv"},{"issue":"7","key":"5854_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","volume":"20","author":"SI Ilyas","year":"2023","unstructured":"Ilyas SI, Affo S, Goyal L, Lamarca A, Sapisochin G, Yang JD, et al. Cholangiocarcinoma\u2014novel biological insights and therapeutic strategies. Nat Rev Clin Oncol. 2023;20(7):470\u201386.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"5854_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"RK Kelley","year":"2020","unstructured":"Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72(2):353\u201363.","journal-title":"J Hepatol"},{"issue":"2","key":"5854_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2023;73(2):198\u2013222.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5854_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/ijms25010461","volume":"25","author":"W Andraus","year":"2023","unstructured":"Andraus W, Tustumi F, de Meira Junior JD, Pinheiro RSN, Waisberg DR, Lopes LD, et al. Molecular profile of intrahepatic cholangiocarcinoma. Int J Mol Sci. 2023;25(1):461.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5854_CR9","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/ueg2.12154","volume":"9","author":"N Barner-Rasmussen","year":"2021","unstructured":"Barner-Rasmussen N, Pukkala E, Hadkhale K, F\u00e4rkkil\u00e4 M. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland. U Eur Gastroenterol J. 2021;9(10):1128\u201335.","journal-title":"U Eur Gastroenterol J"},{"issue":"1","key":"5854_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma. Nat Rev Dis Prim. 2021;7(1):65.","journal-title":"Nat Rev Dis Prim"},{"issue":"9","key":"5854_CR11","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cncr.29692","volume":"122","author":"NF Esnaola","year":"2016","unstructured":"Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122(9):1349\u201369.","journal-title":"Cancer"},{"issue":"2","key":"5854_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","volume":"72","author":"V Mazzaferro","year":"2020","unstructured":"Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72(2):364\u201377.","journal-title":"J Hepatol"},{"issue":"1","key":"5854_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1158\/1078-0432.CCR-23-1317","volume":"30","author":"Q Wu","year":"2024","unstructured":"Wu Q, Ellis H, Siravegna G, Michel AG, Norden BL, de la Cruz FF, et al. Landscape of clinical resistance mechanisms to FGFR inhibitors in FGFR2-altered cholangiocarcinoma. Clin Cancer Res. 2024;30(1):198\u2013208.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"5854_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/polym12030598","volume":"12","author":"I Ali","year":"2020","unstructured":"Ali I, Alsehli M, Scotti L, Tullius Scotti M, Tsai S-T, Yu R-S, et al. Progress in polymeric nano-medicines for theranostic cancer treatment. Polymers. 2020;12(3):598.","journal-title":"Polymers"},{"issue":"2","key":"5854_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.micpath.2012.04.005","volume":"53","author":"I Ali","year":"2012","unstructured":"Ali I, Wani WA, Khan A, Haque A, Ahmad A, Saleem K, et al. Synthesis and synergistic antifungal activities of a pyrazoline based ligand and its copper(II) and nickel(II) complexes with conventional antifungals. Microb Pathog. 2012;53(2):66\u201373.","journal-title":"Microb Pathog"},{"key":"5854_CR16","doi-asserted-by":"publisher","first-page":"1321683","DOI":"10.3389\/fonc.2024.1321683","volume":"14","author":"SM Ruff","year":"2024","unstructured":"Ruff SM, Pawlik TM. Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies. Front Oncol. 2024;14:1321683.","journal-title":"Front Oncol"},{"issue":"12","key":"5854_CR17","doi-asserted-by":"publisher","first-page":"468","DOI":"10.4240\/wjgs.v12.i12.468","volume":"12","author":"T Lee","year":"2020","unstructured":"Lee T, Teng TZJ, Shelat VG. Carbohydrate antigen 19-9\u2014tumor marker: past, present, and future. World J Gastrointest Surg. 2020;12(12):468\u201390.","journal-title":"World J Gastrointest Surg"},{"issue":"6","key":"5854_CR18","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3390\/cancers12061509","volume":"12","author":"R Indellicato","year":"2020","unstructured":"Indellicato R, Zulueta A, Caretti A, Trinchera M. Complementary use of carbohydrate antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in gastrointestinal cancers: biological rationale towards a personalized clinical application. Cancers. 2020;12(6):1509.","journal-title":"Cancers"},{"issue":"25","key":"5854_CR19","doi-asserted-by":"publisher","first-page":"17430","DOI":"10.18632\/oncotarget.24732","volume":"9","author":"J Cuenco","year":"2018","unstructured":"Cuenco J, Wehnert N, Blyuss O, Kazarian A, Whitwell HJ, Menon U, et al. Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis. Oncotarget. 2018;9(25):17430\u201342.","journal-title":"Oncotarget"},{"issue":"3","key":"5854_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jhep.2022.11.011","volume":"78","author":"C Villard","year":"2023","unstructured":"Villard C, Friis-Liby I, Rorsman F, Said K, Warnqvist A, Cornillet M, et al. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis. J Hepatol. 2023;78(3):604\u201313.","journal-title":"J Hepatol"},{"issue":"10","key":"5854_CR21","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1007\/s00595-020-01992-x","volume":"50","author":"T Asaoka","year":"2020","unstructured":"Asaoka T, Kobayashi S, Hanaki T, Iwagami Y, Tomimaru Y, Akita H, et al. Clinical significance of preoperative CA19-9 and lymph node metastasis in intrahepatic cholangiocarcinoma. Surg Today. 2020;50(10):1176\u201386.","journal-title":"Surg Today"},{"key":"5854_CR22","first-page":"298985","volume":"2015","author":"T Yoo","year":"2015","unstructured":"Yoo T, Park S-J, Han S-S, Kim SH, Lee SD, Kim Y-K, et al. Postoperative CA19-9 change is a useful predictor of intrahepatic cholangiocarcinoma survival following liver resection. Dis Mark. 2015;2015:298985.","journal-title":"Dis Mark"},{"issue":"2","key":"5854_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/biology12020213","volume":"12","author":"V Granata","year":"2023","unstructured":"Granata V, Fusco R, De Muzio F, Cutolo C, Grassi F, Brunese MC, et al. Risk assessment and cholangiocarcinoma: diagnostic management and artificial intelligence. Biology. 2023;12(2):213.","journal-title":"Biology"},{"key":"5854_CR24","doi-asserted-by":"publisher","first-page":"154575","DOI":"10.1016\/j.phymed.2022.154575","volume":"109","author":"L Li","year":"2023","unstructured":"Li L, Wang C, Qiu Z, Deng D, Chen X, Wang Q, et al. Triptolide inhibits intrahepatic cholangiocarcinoma growth by suppressing glycolysis via the AKT\/mTOR pathway. Phytomedicine. 2023;109:154575.","journal-title":"Phytomedicine"},{"issue":"7","key":"5854_CR25","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.7150\/ijbs.59068","volume":"17","author":"X Li","year":"2021","unstructured":"Li X, Yu C, Luo Y, Lin J, Wang F, Sun X, et al. Aldolase A enhances intrahepatic cholangiocarcinoma proliferation and invasion through promoting glycolysis. Int J Biol Sci. 2021;17(7):1782\u201394.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"5854_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):70.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"5854_CR27","first-page":"2243","volume":"65","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zuo D, Huang C, Zhao M, Hou Y, Chang J, et al. Relationship between hypoxia and carcinoembryonic antigen and upregulated carcinoembryonic antigen is associated with poor prognosis in breast cancer patients. Clin Lab. 2019;65(12):2243\u201352.","journal-title":"Clin Lab"},{"issue":"1","key":"5854_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12957-022-02870-1","volume":"20","author":"J Wang","year":"2022","unstructured":"Wang J, Wang W, Chen X, Ma D, Du G, Xia T, et al. Laparoscopic versus open hepatectomy for intrahepatic cholangiocarcinoma in patients aged 60 and older: a retrospective cohort study. World J Surg Oncol. 2022;20(1):396.","journal-title":"World J Surg Oncol"},{"key":"5854_CR29","doi-asserted-by":"publisher","first-page":"742544","DOI":"10.3389\/fonc.2021.742544","volume":"11","author":"Y Jinhuan","year":"2021","unstructured":"Jinhuan Y, Yi W, Yuanwen Z, Delin M, Xiaotian C, Yan W, et al. Laparoscopic versus open surgery for early-stage intrahepatic cholangiocarcinoma after mastering the learning curve: a multicenter data-based matched study. Front Oncol. 2021;11:742544.","journal-title":"Front Oncol"},{"issue":"1","key":"5854_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","volume":"40","author":"L Dong","year":"2022","unstructured":"Dong L, Lu D, Chen R, Lin Y, Zhu H, Zhang Z, et al. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell. 2022;40(1):70.","journal-title":"Cancer Cell"},{"issue":"3","key":"5854_CR31","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/hep.31829","volume":"74","author":"T Boerner","year":"2021","unstructured":"Boerner T, Drill E, Pak LM, Nguyen B, Sigel CS, Doussot A, et al. Genetic determinants of outcome in intrahepatic cholangiocarcinoma. Hepatology. 2021;74(3):1429\u201344.","journal-title":"Hepatology"},{"issue":"13","key":"5854_CR32","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/j.celrep.2017.06.008","volume":"19","author":"F Farshidfar","year":"2017","unstructured":"Farshidfar F, Zheng S, Gingras M-C, Newton Y, Shih J, Robertson AG, et al. Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles. Cell Rep. 2017;19(13):2878\u201380.","journal-title":"Cell Rep"},{"issue":"4","key":"5854_CR33","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s12072-019-09954-3","volume":"13","author":"KS Ahn","year":"2019","unstructured":"Ahn KS, O\u2019Brien D, Kang YN, Mounajjed T, Kim YH, Kim T-S, et al. Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approach. Hepatol Int. 2019;13(4):490\u2013500.","journal-title":"Hepatol Int"},{"issue":"1","key":"5854_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2017.05.009","volume":"32","author":"J Chaisaingmongkol","year":"2017","unstructured":"Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM, et al. Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma. Cancer Cell. 2017;32(1):57.","journal-title":"Cancer Cell"},{"issue":"4","key":"5854_CR35","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","volume":"144","author":"D Sia","year":"2013","unstructured":"Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, et al. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology. 2013;144(4):829\u201340.","journal-title":"Gastroenterology"},{"issue":"4","key":"5854_CR36","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","volume":"142","author":"JB Andersen","year":"2012","unstructured":"Andersen JB, Spee B, Blechacz BR, Avital I, Komuta M, Barbour A, et al. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology. 2012;142(4):1021.","journal-title":"Gastroenterology"},{"issue":"7938","key":"5854_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue R, Zhang Q, Cao Q, Kong R, Xiang X, Liu H, et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature. 2022;612(7938):141\u20137.","journal-title":"Nature"},{"issue":"51","key":"5854_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg3750","volume":"7","author":"R Wu","year":"2021","unstructured":"Wu R, Guo W, Qiu X, Wang S, Sui C, Lian Q, et al. Comprehensive analysis of spatial architecture in primary liver cancer. Sci Adv. 2021;7(51): eabg3750.","journal-title":"Sci Adv"},{"issue":"3","key":"5854_CR39","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141.","journal-title":"Innovation"},{"issue":"13","key":"5854_CR40","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573.","journal-title":"Cell"},{"issue":"12","key":"5854_CR41","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16(12):1289\u201396.","journal-title":"Nat Methods"},{"issue":"6","key":"5854_CR42","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-023-02371-y","volume":"29","author":"Y Chu","year":"2023","unstructured":"Chu Y, Dai E, Li Y, Han G, Pei G, Ingram DR, et al. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nat Med. 2023;29(6):1550\u201362.","journal-title":"Nat Med"},{"issue":"6190","key":"5854_CR43","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344(6190):1396\u2013401.","journal-title":"Science"},{"issue":"1","key":"5854_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yang S, Ma J, Chen Z, Song G, Rao D, et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov. 2022;12(1):134\u201353.","journal-title":"Cancer Discov"},{"issue":"10","key":"5854_CR45","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14(10):979\u201382.","journal-title":"Nat Methods"},{"issue":"1","key":"5854_CR46","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan C-H, et al. Inference and analysis of cell-cell communication using cell chat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"2","key":"5854_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys R, Saelens W, Saeys Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat Methods. 2020;17(2):159\u201362.","journal-title":"Nat Methods"},{"issue":"2","key":"5854_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nchembio.1986","volume":"12","author":"MG Rees","year":"2016","unstructured":"Rees MG, Seashore-Ludlow B, Cheah JH, Adams DJ, Price EV, Gill S, et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat Chem Biol. 2016;12(2):109\u201316.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"5854_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131.","journal-title":"Mol Cancer"},{"issue":"1","key":"5854_CR50","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","volume":"20","author":"C Li","year":"2021","unstructured":"Li C, Teixeira AF, Zhu H-J, Ten Dijke P. Cancer associated-fibroblast-derived exosomes in cancer progression. Mol Cancer. 2021;20(1):154.","journal-title":"Mol Cancer"},{"issue":"1","key":"5854_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cas.15609","volume":"114","author":"Y Yamamoto","year":"2023","unstructured":"Yamamoto Y, Kasashima H, Fukui Y, Tsujio G, Yashiro M, Maeda K. The heterogeneity of cancer-associated fibroblast subpopulations: their origins, biomarkers, and roles in the tumor microenvironment. Cancer Sci. 2023;114(1):16\u201324.","journal-title":"Cancer Sci"},{"issue":"15","key":"5854_CR52","doi-asserted-by":"publisher","first-page":"12032","DOI":"10.3390\/ijms241512032","volume":"24","author":"E Vassiliou","year":"2023","unstructured":"Vassiliou E, Farias-Pereira R. Impact of lipid metabolism on macrophage polarization: implications for inflammation and tumor immunity. Int J Mol Sci. 2023;24(15):12032.","journal-title":"Int J Mol Sci"},{"key":"5854_CR53","doi-asserted-by":"publisher","first-page":"110719","DOI":"10.1016\/j.cellsig.2023.110719","volume":"108","author":"J Tian","year":"2023","unstructured":"Tian J, Zhang L, La X, Fan X, Li A, Wu C, et al. Tumor-secreted GRP78 induces M2 polarization of macrophages by promoting lipid catabolism. Cell Signal. 2023;108:110719.","journal-title":"Cell Signal"},{"issue":"1","key":"5854_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12944-023-01807-1","volume":"22","author":"X Qiao","year":"2023","unstructured":"Qiao X, Hu Z, Xiong F, Yang Y, Peng C, Wang D, et al. Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy. Lipids Health Dis. 2023;22(1):45.","journal-title":"Lipids Health Dis"},{"key":"5854_CR55","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3389\/fonc.2019.00854","volume":"9","author":"H Yang","year":"2019","unstructured":"Yang H, Wang J, Li Z, Yang Y, Yang L, Zhang Y, et al. Risk factors and outcomes of early relapse after curative resection of intrahepatic cholangiocarcinoma. Front Oncol. 2019;9:854.","journal-title":"Front Oncol"},{"issue":"12","key":"5854_CR56","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41568-018-0076-6","volume":"18","author":"S Li","year":"2018","unstructured":"Li S, Balmain A, Counter CM. A model for RAS mutation patterns in cancers: finding the sweet spot. Nat Rev Cancer. 2018;18(12):767\u201377.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"5854_CR57","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.cell.2020.09.044","volume":"183","author":"D Kim","year":"2020","unstructured":"Kim D, Xue JY, Lito P. Targeting KRAS(G12C): from inhibitory mechanism to modulation of antitumor effects in patients. Cell. 2020;183(4):850\u20139.","journal-title":"Cell"},{"issue":"9","key":"5854_CR58","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"5854_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jamasurg.2021.5679","volume":"157","author":"S-L Zhou","year":"2022","unstructured":"Zhou S-L, Xin H-Y, Sun R-Q, Zhou Z-J, Hu Z-Q, Luo C-B, et al. Association of KRAS variant subtypes with survival and recurrence in patients with surgically treated intrahepatic cholangiocarcinoma. JAMA Surg. 2022;157(1):59\u201365.","journal-title":"JAMA Surg"},{"issue":"7947","key":"5854_CR60","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-05661-6","volume":"614","author":"CR Bartman","year":"2023","unstructured":"Bartman CR, Weilandt DR, Shen Y, Lee WD, Han Y, TeSlaa T, et al. Slow TCA flux and ATP production in primary solid tumours but not metastases. Nature. 2023;614(7947):349\u201357.","journal-title":"Nature"},{"issue":"1","key":"5854_CR61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/ijms24010012","volume":"24","author":"H-S Chae","year":"2023","unstructured":"Chae H-S, Hong S-T. Overview of cancer metabolism and signaling transduction. Int J Mol Sci. 2023;24(1):12.","journal-title":"Int J Mol Sci"},{"key":"5854_CR62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2024.03.001","volume":"100","author":"D Yadav","year":"2024","unstructured":"Yadav D, Yadav A, Bhattacharya S, Dagar A, Kumar V, Rani R. GLUT and HK: two primary and essential key players in tumor glycolysis. Semin Cancer Biol. 2024;100:17\u201327.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"5854_CR63","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2174\/1874467214666210811145752","volume":"15","author":"X Zheng","year":"2022","unstructured":"Zheng X, Fan H, Liu Y, Wei Z, Li X, Wang A, et al. Hypoxia boosts aerobic glycolysis in carcinoma: a complex process for tumour development. Curr Mol Pharmacol. 2022;15(3):487\u2013501.","journal-title":"Curr Mol Pharmacol"},{"key":"5854_CR64","doi-asserted-by":"publisher","first-page":"108994","DOI":"10.1016\/j.intimp.2022.108994","volume":"110","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang X, Meng Y, Xu X, Zuo D. The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype. Int Immunopharmacol. 2022;110:108994.","journal-title":"Int Immunopharmacol"},{"key":"5854_CR65","doi-asserted-by":"publisher","first-page":"1034205","DOI":"10.3389\/fonc.2023.1034205","volume":"13","author":"L Singh","year":"2023","unstructured":"Singh L, Nair L, Kumar D, Arora MK, Bajaj S, Gadewar M, et al. Hypoxia induced lactate acidosis modulates tumor microenvironment and lipid reprogramming to sustain the cancer cell survival. Front Oncol. 2023;13:1034205.","journal-title":"Front Oncol"},{"key":"5854_CR66","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fimmu.2016.00052","volume":"7","author":"S Romero-Garcia","year":"2016","unstructured":"Romero-Garcia S, Moreno-Altamirano MMB, Prado-Garcia H, S\u00e1nchez-Garc\u00eda FJ. Lactate contribution to the tumor microenvironment: mechanisms, effects on immune cells and therapeutic relevance. Front Immunol. 2016;7:52.","journal-title":"Front Immunol"},{"issue":"2","key":"5854_CR67","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41379-020-00656-y","volume":"34","author":"N Guedj","year":"2021","unstructured":"Guedj N, Blaise L, Cauchy F, Albuquerque M, Soubrane O, Paradis V. Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma. Mod Pathol. 2021;34(2):408\u201316.","journal-title":"Mod Pathol"},{"issue":"3","key":"5854_CR68","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/hep.31092","volume":"72","author":"S Job","year":"2020","unstructured":"Job S, Rapoud D, Dos Santos A, Gonzalez P, Desterke C, Pascal G, et al. Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma. Hepatology. 2020;72(3):965\u201381.","journal-title":"Hepatology"},{"issue":"6","key":"5854_CR69","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.3390\/ijms25063142","volume":"25","author":"I Barba","year":"2024","unstructured":"Barba I, Carrillo-Bosch L, Seoane J. Targeting the warburg effect in cancer: where do we stand? Int J Mol Sci. 2024;25(6):3142.","journal-title":"Int J Mol Sci"},{"issue":"45","key":"5854_CR70","doi-asserted-by":"publisher","first-page":"9933","DOI":"10.3748\/wjg.v22.i45.9933","volume":"22","author":"R-Z Shang","year":"2016","unstructured":"Shang R-Z, Qu S-B, Wang D-S. Reprogramming of glucose metabolism in hepatocellular carcinoma: progress and prospects. World J Gastroenterol. 2016;22(45):9933\u201343.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"5854_CR71","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1158\/2159-8290.CD-20-0569","volume":"11","author":"MZ Madden","year":"2021","unstructured":"Madden MZ, Rathmell JC. The complex integration of T-cell metabolism and immunotherapy. Cancer Discov. 2021;11(7):1636\u201343.","journal-title":"Cancer Discov"},{"issue":"18","key":"5854_CR72","doi-asserted-by":"publisher","first-page":"9878","DOI":"10.3390\/ijms22189878","volume":"22","author":"M-Y Chou","year":"2021","unstructured":"Chou M-Y, Yang M-H. Interplay of immunometabolism and epithelial-mesenchymal transition in the tumor microenvironment. Int J Mol Sci. 2021;22(18):9878.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5854_CR73","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12916-021-01925-6","volume":"19","author":"K-H Ho","year":"2021","unstructured":"Ho K-H, Huang T-W, Shih C-M, Lee Y-T, Liu A-J, Chen P-H, et al. Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment. BMC Med. 2021;19(1):59.","journal-title":"BMC Med"},{"key":"5854_CR74","doi-asserted-by":"publisher","first-page":"1222575","DOI":"10.3389\/fonc.2023.1222575","volume":"13","author":"RF Zaarour","year":"2023","unstructured":"Zaarour RF, Ribeiro M, Azzarone B, Kapoor S, Chouaib S. Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance. Front Oncol. 2023;13:1222575.","journal-title":"Front Oncol"},{"key":"5854_CR75","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semcancer.2022.12.011","volume":"88","author":"C Liao","year":"2023","unstructured":"Liao C, Liu X, Zhang C, Zhang Q. Tumor hypoxia: from basic knowledge to therapeutic implications. Semin Cancer Biol. 2023;88:172\u201386.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"5854_CR76","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10238-024-01501-1","volume":"24","author":"J Ciep\u0142a","year":"2024","unstructured":"Ciep\u0142a J, Smolarczyk R. Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies. Clin Exp Med. 2024;24(1):235.","journal-title":"Clin Exp Med"},{"key":"5854_CR77","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.3389\/fimmu.2019.02965","volume":"10","author":"P Dobosz","year":"2019","unstructured":"Dobosz P, Dzieci\u0105tkowski T. The intriguing history of cancer immunotherapy. Front Immunol. 2019;10:2965.","journal-title":"Front Immunol"},{"key":"5854_CR78","doi-asserted-by":"publisher","first-page":"16382","DOI":"10.1038\/srep16382","volume":"5","author":"J-H Gao","year":"2015","unstructured":"Gao J-H, Wang C-H, Tong H, Wen S-L, Huang Z-Y, Tang C-W. Targeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer. Sci Rep. 2015;5:16382.","journal-title":"Sci Rep"},{"issue":"4","key":"5854_CR79","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1158\/1078-0432.CCR-11-1507","volume":"18","author":"MP Morelli","year":"2012","unstructured":"Morelli MP, Tentler JJ, Kulikowski GN, Tan A-C, Bradshaw-Pierce EL, Pitts TM, et al. Preclinical activity of the rational combination of selumetinib (AZD6244) in combination with vorinostat in KRAS-mutant colorectal cancer models. Clin Cancer Res. 2012;18(4):1051\u201362.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"5854_CR80","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S1470-2045(20)30321-1","volume":"21","author":"V Subbiah","year":"2020","unstructured":"Subbiah V, Lassen U, \u00c9lez E, Italiano A, Curigliano G, Javle M, et al. Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial. Lancet Oncol. 2020;21(9):1234\u201343.","journal-title":"Lancet Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05854-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05854-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05854-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T17:18:22Z","timestamp":1731691102000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05854-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5854"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05854-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"21 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Peking University People\u2019s Hospital Ethics Committee. All procedures involving human participants were performed in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1031"}}